Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by ICT1111on Mar 12, 2020 7:33am
78 Views
Post# 30797610

RE:RE:RE:RE:RE:RE:Re: XTR

RE:RE:RE:RE:RE:RE:Re: XTRMight the negativity stem from the fact that there has been a change in power within the company and the new directors have just voted to do the opposite to what 55million shares told them to do 48 hours earlier?
This company is owned by the shareholders. We appoint the directors to run the company as we want it to be run. We vote on issues at AGM's and EM's ....... to have voted for one thing and have the officers do the opposite is a disgrace, if you are prepared to lie back and say 'ah well' fair enough, kiss good bye to your hard earned, I, however, am not.
The restructuring group had a signed term sheet, they had the agreement in principal from the TSX to rsume trading, they had the support of a large group of shareholders, they had the commitment of funds, they had a strong capable board of directors lined up, they had critical suppliers on side ........ then came the demand from Bakema for an additional $2million, and the demand that Medical pay all of Globals outsanding debts, most of which are to family members and associated hangers on (on the 17th of Jan Phil Bendick popped in an invoice to Global for $200,000) ......... the restructuring group are, by and large, prepared to work for nothing until this device is through FDA and in revenue ....... Global has rewarded failure and continues to want to be paid as a higher priority than getting the device commercialised. This breaks the first rule of business, make the money first then you can divide it up .......
Bullboard Posts